Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gabriel Areoye"'
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 10, Iss 3, Pp 275-278 (2020)
Introduction Gilteritinib is a FLT3 kinase inhibitor approved for FLT3-mutated acute myeloid leukemia (AML). We present a case of febrile neutropenia and neutrophilic dermatosis consistent with Sweet’s syndrome (SS). Case history A 55-year-old woma
Externí odkaz:
https://doaj.org/article/6fc920b494754388acaed70950bb1f89
Autor:
Andrew Okpe, Gabriel Areoye, Onyinyechi Ogbulafor, Ralf Habermann, Mariu Duggan, Harvey Murff
Publikováno v:
Journal of the American Medical Directors Association. 24:B30
Autor:
Adeolu O Oladunjoye, Oluwaseun Shogbesan, Ibiyemi O Oke, Rashmi Dhital, Asad Jehangir, Gabriel Areoye, Oreoluwa Oladiran, Olubunmi O Oladunjoye, DilliRam Poudel
Publikováno v:
Cureus
Background Non-alcoholic fatty liver disease (NAFLD), one of the leading causes of end-stage liver disease, is known to be associated with obesity. However, only a few studies in the United States (US) have described non-obese NAFLD, most of which we
Autor:
Gabriel Areoye, Eric Elgin, Anthony Licata, Adeolu O Oladunjoye, Oreoluwa Oladiran, Olubunmi O Oladunjoye
Publikováno v:
The American Journal of Case Reports
Patient: Female, 52-year-old Final Diagnosis: Paravalvular leak Symptoms: Abdominal discomfort • Early satiety • lower extremity edema • nausea • orthopnea • shortness of breath Medication: — Clinical Procedure: Percutaneous closure of mi
Publikováno v:
Journal of the American College of Cardiology. 77:2041